(Q50148762)

Counterpoint: Should an attempt be made to withdraw inhaled corticosteroids in all patients with stable GOLD 3 (30% ≤ FEV1 < 50% predicted) COPD? No. (English)

1 reference

stated in

Europe PubMed Central

26 February 2018

http://europepmc.org/abstract/MED/29410364

author name string

Ian D Pavord

series ordinal

1

1 reference

stated in

Europe PubMed Central

26 February 2018

http://europepmc.org/abstract/MED/29410364

language of work or name

English

0 references

publication date

1 February 2018

1 reference

stated in

Europe PubMed Central

26 February 2018

http://europepmc.org/abstract/MED/29410364

published in

Chest

1 reference

stated in

Europe PubMed Central

26 February 2018

http://europepmc.org/abstract/MED/29410364

Identifiers

DOI

10.1016/J.CHEST.2018.01.030

1 reference

stated in

Europe PubMed Central

26 February 2018

http://europepmc.org/abstract/MED/29410364

Fatcat ID

release_7vzfhipduzfqljx2bpxqdl5kje

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/7vzfhipduzfqljx2bpxqdl5kje

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed ID

29410364

1 reference

stated in

Europe PubMed Central

26 February 2018

http://europepmc.org/abstract/MED/29410364

(Q50148762)

Counterpoint: Should an attempt be made to withdraw inhaled corticosteroids in all patients with stable GOLD 3 (30% ≤ FEV1 < 50% predicted) COPD? No.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)